ACLY antibody (AA 306-502)
-
- Target See all ACLY Antibodies
- ACLY (ATP Citrate Lyase (ACLY))
-
Binding Specificity
- AA 306-502
-
Reactivity
- Human, Mouse, Rat, Monkey
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This ACLY antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (fixed cells) (IF/ICC)
- Purification
- Purified antibody
- Immunogen
- Purified recombinant fragment of human ACLY (AA: 306-502) expressed in E. Coli.
- Isotype
- IgG1
- Top Product
- Discover our top product ACLY Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- ACLY (ATP Citrate Lyase (ACLY))
- Alternative Name
- ACLY (ACLY Products)
- Background
- ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzyme is a tetramer (relative molecular weight approximately 440,000) of apparently identical subunits. It catalyzes the formation of acetyl-CoA and oxaloacetate from citrate and CoA with a concomitant hydrolysis of ATP to ADP and phosphate. The product, acetyl-CoA, serves several important biosynthetic pathways, including lipogenesis and cholesterogenesis.
- Molecular Weight
- 125 kDa
- Gene ID
- 47
- UniProt
- P53396
- Pathways
- Warburg Effect
-